Physician profile
Mark D Wild
NPI 1891759916
$771.21
in general payments reported to CMS, 2019-2025
17 companies · $409 in 2025
The $409 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.12 · 2021: $20.47 · 2022: $16.39 · 2023: $37.22 · 2024: $272 · 2025: $409.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $111.68 | 2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $95.85 | 2023-2025 | Slynd |
| Sage Therapeutics, LLC | $91.99 | 2024-2025 | Zurzuvae |
| Novo Nordisk INC | $84.16 | 2023-2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $79.42 | 2022-2025 | |
| Astellas Pharma US INC | $56.48 | 2024 | Veozah |
| Mayne Pharma Commercial LLC | $37.03 | 2024-2025 | |
| Coopersurgical, INC. | $35.89 | 2024 | Paragard T 380a |
| Pfizer INC. | $32.08 | 2020-2024 | |
| Organon LLC | $23.80 | 2024-2025 | Nexplanon |
| Daiichi Sankyo INC. | $23.06 | 2025 | Injectafer |
| Abbvie INC. | $22.10 | 2024 | |
| Supernus Pharmaceuticals, INC. | $21.40 | 2025 | Qelbree |
| Alydia Health | $20.47 | 2021 | |
| Exact Sciences Corporation | $14.56 | 2024 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $14.13 | 2024 | Twirla |
| Channel Medsystems, INC. | $7.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wild listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.